Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find various ways to sell products online for quick cash and boost your income. Start today with effective strategies and tips.
23,466 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Tesla isn’t just selling cars—it's building an autonomy and energy ecosystem. This piece examines whether tesla: wall...
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Corporate treasuries are redefining crypto investing. This deep dive looks at how Strategy amassed a sizable Bitcoin ...
Industry watchers say Brookfield Infrastructure could quietly leverage a wave of rail asset divestitures tied to the ...
As inflation and market volatility persist into 2026, two smart social security claiming strategies help married coup...
Stylecraft Builders maintains momentum in Texas by deploying a precise, micro approach to margins and pace. With 2025...
New data shows the median American holds just $8,000 in savings while the average climbs to $62,410, signaling risk f...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...
As 2028 approaches, pre-retirees face a pivotal window to optimize savings, reduce risk, and improve retirement incom...
PepsiCo stock faces a fresh price prediction this popular blue-chip dividend stock, with an upside case built on inte...